跳至主要内容
临床试验/NCT04681352
NCT04681352已完成不适用

Prospective, Evaluator-blind, Multicenter Study to Assess the Safety and Effectiveness of Treatment With the Octave System for Improving Lines and Wrinkles of the décolleté

Merz North America, Inc.10 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2020年12月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
99
试验地点
10
主要终点
Percentage of Treated Subjects With Improvement in Lines and Wrinkles of the Décolleté at Day 90

研究概览

简要总结

To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

While there was only one arm, Outcome Assessors were masked to pre- vs post-treatment images.

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Moderate to severe fine lines, wrinkles, laxity, and crepiness of the décolleté that is amenable to improvement with non-invasive intervention and is not severe enough for surgical intervention.

排除标准

  • •Presence of an active systemic or local skin disease that may affect wound healing.
  • •Scarring in area(s) to be treated.
  • •Active implants (e.g., pacemakers or defibrillators), ports, or metallic implants in area(s) to be treated.
  • •Breast implants or is planning to receive breast implants during the study.
  • •Inability to take pre-treatment medications due to a pre-existing condition, medication allergy, or medical issue that, at the discretion of the treating investigator, is contraindicated.

研究组 & 干预措施

Octave System

Experimental

Single treatment of décolleté tissue.

干预措施: Octave-Ultherapy treatment (Device)

结局指标

主要结局

Percentage of Treated Subjects With Improvement in Lines and Wrinkles of the Décolleté at Day 90

时间窗: Day 90

Improvement in lines and wrinkles of the décolleté were determined after comparing Day 90 photographs with baseline photographs. Improvement was concluded if at least two evaluators assessed the Day 90 photographs as "improved" compared to baseline.

次要结局

  • Percentage of Treated Subjects With Improvement in Lines and Wrinkles of the Décolleté at Day 180(Day 180)
  • Number of Subjects With Treatment-emergent Adverse Events (TEAEs)(From Day 1 up to end of the study (Up to Day 180))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验